Clinical Trials for SCLC,Extensive Stage

Find clinical trials for sclc,extensive stage. Discover research opportunities and treatment options in your area.

6 Active Trials Found

Showing 6 trials on this page

Page 1 of 1

Pembrolizumab and Olaparib Treatment of Extensive Small Cell Lung Cancer (ES-SCLC)

NCT ID: NCT05623319

This clinical trial is studying the combination of two medications, Pembrolizumab and Olaparib, to see if they can effectively treat patients with untreated Extensive Stage Small Cell Lung Cancer (...

Recruiting

Phase: PHASE2 Type: interventional Locations: Bari, , Italy, Padova, , Italy +11 more

Niraparib Added to Anti-PD-L1 Antibody Maintenance in SLFN11-positive, Extensive-disease SCLC

NCT ID: NCT05718323

The RAISE clinical trial is studying a new treatment approach for patients with extensive-stage small cell lung cancer (SCLC) who have a specific marker called SLFN11. In this trial, researchers ar...

Recruiting

Phase: PHASE2 Type: interventional Locations: Aarau, , Switzerland, Baden, , Switzerland +20 more

Study of RYZ101 in Combination With SoC in Subjects With SSTR+ ES-SCLC

NCT ID: NCT05595460

This clinical trial is looking at a new treatment called RYZ101, which is being tested alongside standard therapies for patients with extensive stage small cell lung cancer (ES-SCLC) who have not b...

Recruiting

Phase: PHASE1 Type: interventional Locations: Rochester, Minnesota, United States, Jacksonville, Florida, United States +27 more

A Multicenter, Real-world Study of Adebrelimab in the Treatment of Extensive Stage Small Cell Lung Cancer

NCT ID: NCT06267170

This clinical trial is studying a treatment called Adebrelimab for patients with extensive stage small cell lung cancer (SCLC). The goal is to gather information about how safe and effective this t...

Not yet recruiting

Type: observational

WBRT With Hippocampal-avoidance Technique Followed by SRT for Extensive-stage SCLC With Baseline Brain Metastases

NCT ID: NCT06243003

This clinical trial is studying a new treatment approach for patients with extensive-stage small cell lung cancer (SCLC) who also have brain metastases, which means the cancer has spread to the bra...

Recruiting

Phase: PHASE1 Type: interventional Locations: Shanghai, Shanghai, China, Shanghai, , China

TRT for ES-SCLC After First Line Treatment With Immune Checkpoint Inhibitors

NCT ID: NCT05544149

This clinical trial is studying the use of thoracic radiotherapy, a type of targeted radiation treatment, for patients with extensive stage small cell lung cancer (ES-SCLC) who have already receive...

Recruiting

Phase: PHASE2 Type: interventional Locations: Hangzhou, Zhejiang, China

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions